Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other Non-Current Liabilities (2018 - 2025)

Historic Other Non-Current Liabilities for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to $427000.0.

  • Neurogene's Other Non-Current Liabilities fell 3390.09% to $427000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $427000.0, marking a year-over-year decrease of 3390.09%. This contributed to the annual value of $718000.0 for FY2024, which is 2862.82% down from last year.
  • Neurogene's Other Non-Current Liabilities amounted to $427000.0 in Q3 2025, which was down 3390.09% from $738000.0 recorded in Q2 2025.
  • In the past 5 years, Neurogene's Other Non-Current Liabilities ranged from a high of $1.0 million in Q4 2023 and a low of $427000.0 during Q3 2025
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $728000.0 (2024), whereas its average is $730875.0.
  • The largest annual percentage gain for Neurogene's Other Non-Current Liabilities in the last 5 years was 292.89% (2025), contrasted with its biggest fall of 3390.09% (2025).
  • Over the past 3 years, Neurogene's Other Non-Current Liabilities (Quarter) stood at $1.0 million in 2023, then dropped by 28.63% to $718000.0 in 2024, then plummeted by 40.53% to $427000.0 in 2025.
  • Its Other Non-Current Liabilities was $427000.0 in Q3 2025, compared to $738000.0 in Q2 2025 and $738000.0 in Q1 2025.